Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Laura Munoz-Arcos"'
Autor:
Oussama Abla, Stephen Peeke, Irem Eldem, Marianne D. van de Wetering, Jennifer Picarsic, Kseniya Petrova-Drus, Robert B. Lorsbach, Jan A M van Laar, Paul Geraeds Kemps, Sylvie Fraitag, Sébastien Héritier, Kristian T. Schafernak, Amy A. Swanson, Eli L. Diamond, Raf Sciot, Karen Ernestus, Mariko Suchi, Nabeel R. Yaseen, Sanda Alexandrescu, Laura Sophia Hiemcke-Jiwa, Matthew Collin, Ingrid S Tam, Sabrina Rossi, Benjamin H. Durham, F J Sherida H Woei-A-Jin, James A. Whitlock, Brianna Empringham, Laura Munoz-Arcos, Falko Fend, Olga Gryniewicz-Kwiatkowska, Majid Madni, Verena Wiegering, Kerry Turner, Dina El Demellawy, Gianpiero Tamburrini, Aditya Raghunathan, Lucas R. Massoth, Carel J. M. van Noesel, Robert Möhle, Cor van den Bos, Jacinthe Bonneau-Lagacherie, Somak Roy, Pasquale M Barbaro, Andreas Beilken, Stefania Gaspari, Jean-François Emile, David D. Grier, Claire Lamaison, Kee Kiat Yeo, Jean Donadieu, Jon M Brandt, Laure Farnault, Friedrich Feuerhake, Marie-Laure Jullie, Uta Flucke, Pancras C.W. Hogendoorn, Astrid G. S. van Halteren, Antje Bornemann, Bryan A. Sisk, Tina Méry, Joanna Weinstein, Ashish R Kumar, Robert M. Verdijk, V. Baykov, Alysa A Poulin, Mandy M Atkinson, VG Potapenko, Vaish Sridhar, Julien Haroche, Zofia Hélias-Rodzewicz, Shipra Garg, Susan Picton, Michael M. Henry, Jackie Allotey, Daniel Leino, Nishant Tiwari, Martin Ebinger, Jason L Hornick, Bożenna Dembowska-Bagińska, Marco Gessi, Dmitry A Evseev
Publikováno v:
Blood
Blood, 139(2), 256-280. AMER SOC HEMATOLOGY
Blood, 139(2), 256-280. American Society of Hematology
Blood, 2022, 139 (2), pp.256-280. ⟨10.1182/blood.2021013338⟩
Blood, 139, 256-280
Blood, 139, 2, pp. 256-280
Blood, 139(2), 256-280. AMER SOC HEMATOLOGY
Blood, 139(2), 256-280. American Society of Hematology
Blood, 2022, 139 (2), pp.256-280. ⟨10.1182/blood.2021013338⟩
Blood, 139, 256-280
Blood, 139, 2, pp. 256-280
Contains fulltext : 249882.pdf (Publisher’s version ) (Closed access) ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in 3 infants with multisystemic disease involving the liver and hematopoietic system.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe217ff12356ba76b44d2d33c6d436e
https://hdl.handle.net/1887/3563700
https://hdl.handle.net/1887/3563700
Purpose: The three CDK4/6 inhibitors (CDK4/6i) approved for use in HR-positive/HER2-negative metastatic breast cancer (MBC), palbociclib, ribociclib, and abemaciclib, are generally well tolerated but their most common toxicity is neutropenia. Within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e71dcbcee4cd8487032028e5b94064
https://doi.org/10.21203/rs.3.rs-1186162/v1
https://doi.org/10.21203/rs.3.rs-1186162/v1